| Podcast

2018 was not a good year to be on the wrong side of medical necessity when it came to drug testing and ongoing prescribing of controlled medication or substance abuse treatment programs.

2019 is likely to be an expensive year for those who do not proactively take steps to understand medical...

| Podcast

2018 was not a good year to be on the wrong side of medical necessity when it came to drug testing and ongoing prescribing of controlled medication or substance abuse treatment programs.

2019 is likely to be an expensive year for those who do not proactively take steps to understand medical...

| Podcast

At the 2018 Department of Justice (DOJ) Opioid Summit, then-Attorney General Jeff Sessions remarked that opioid prescribing had reached its lowest point in 18 years. Still, the DOJ is committed to reducing opioid analgesic prescriptions an additional 30% to 33% within the next 3 years. More than...

| Video

PAINWeek faculty favorites Jen Bolen and Dr. Doug Gourlay illustrate the connection between carrying out licensing board directives on using opioids to treat pain and reasonably prudent medical decision-making, and don’t forget documentation. What should a practitioner do in a court of law if called...

| Article

Expert Witness Testimony

  • Expert witness testimony in the US has contributed to courtroom confusion regarding the practitioner’s duties & responsibilities; it’s led to an attempt to put some uniform recipe into all prescribing and it’s neglected the patients.
  • Many experts are hired because they...

| Video

Problems related to prescription painkillers and heroin lead the news almost every night. Tens of thousands of Americans die every year from unintentionally overdosing on these drugs. Why do we have this problem? Dr. Gonzalez and Mr. Fazio assess the drug problem in the United States, and discuss...

| Video

Intensifying government scrutiny suggests that prescribers pay close attention to licensing board, payer and professional society guidance on ordering and using drug tests when treatment involves opioid therapy. Attorney Bolen sketches the changing regulatory landscape and how prescribers should...

Subscribe to legal issues

Sign-Up